Proto Labs Earnings Call: Record Sales, Transformative 2026
Proto Labs Inc ((PRLB)) has held its Q4 earnings call. Read on for the main highlights of the call.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Proto Labs’ Earnings Call Balances Record Results With Transformation Agenda
Proto Labs Inc. struck an optimistic but measured tone in its latest earnings call, highlighting record quarterly and annual revenue, expanding factory margins, strong CNC and sheet metal demand, and solid cash generation. Management positioned 2026 as a deliberate “year of transformation,” where the company will invest in strategic initiatives and operational changes to support higher long-term growth and margin expansion, even as it contends with pressure in Europe, weaker prototyping activity, and short-term cost headwinds.
Record Revenue Underscores Durable Demand
Proto Labs reported its highest-ever quarterly revenue in the fourth quarter at $136.5 million, up 11% year over year in constant currencies. Full-year 2025 revenue reached a record $533.1 million, representing 5.7% growth in constant currencies. These results demonstrate resilient demand for the company’s digital manufacturing platform despite macro uncertainty, and they provide a solid base from which management aims to drive its next phase of growth.
Revenue Per Customer and Contact Shows Share-of-Wallet Gains
A key highlight was the company’s ability to deepen relationships with existing customers. Revenue per customer grew 13% in 2025, while revenue per contact accelerated roughly 23% in the fourth quarter. This indicates Proto Labs is not just adding new accounts but successfully capturing a larger share of customers’ manufacturing spend, an important lever for growth as customer acquisition becomes more competitive and costly.
CNC and Sheet Metal Businesses Power Growth
CNC machining and sheet metal services were standout performers. Overall CNC revenue rose 16.7% year over year, with U.S. CNC revenue up 25% for 2025 and surging 35% in the fourth quarter alone. Sheet metal revenue increased 12% year over year. Management pointed to robust demand from aerospace and defense-related markets—including drones, satellites, rockets, and robotics—as key growth drivers, suggesting Proto Labs is well-positioned in high-spec, innovation-heavy end markets.
Factory Margins Trend Higher on Scale and Productivity
Profitability in Proto Labs’ own factories continued to improve. Fourth quarter non-GAAP gross margin reached 44.8%, up 140 basis points from a year earlier, while full-year factory non-GAAP gross margin climbed to 49%, an improvement of 70 basis points. Management attributed these gains to volume growth and factory productivity improvements, reinforcing the strategic value of its in-house production footprint as a margin engine.
Balanced Growth Across Factory and Network Channels
The company’s hybrid model—combining internal factories with a partner network—also showed healthy growth. Network revenue increased 13.8% for the year, while factory revenue expanded alongside it. In the fourth quarter, $30.5 million of revenue was fulfilled through the network, up 11.2% in constant currencies. This balance suggests Proto Labs is successfully using both channels to meet varied customer needs, from quick-turn internal production to more complex outsourced jobs.
Robust Cash Generation and Debt-Free Balance Sheet
Financial flexibility remains a notable strength. Proto Labs generated $74.5 million in cash from operations during 2025 and returned $43 million to shareholders through stock repurchases. The company ended the year with $142.4 million in cash and investments and no debt. This balance sheet gives management room to fund its transformation agenda, invest in new capabilities, and continue returning capital to shareholders.
Certifications and Production Capabilities Target Medical Growth
Proto Labs is pushing deeper into production work, particularly in regulated industries. The company achieved ISO 13485 certification for its U.S. factory injection molding operations—a critical standard for medical device manufacturing. It also launched pilots with two medical device customers focused on high-precision production volumes. These steps position Proto Labs to capture more recurring production revenue rather than relying predominantly on one-off prototyping jobs.
European Weakness Triggers Strategic Reset
Europe remained a soft spot in an otherwise strong year. Revenue in the region declined 8.1% in the fourth quarter and 7% for the full year, in constant currencies. Management acknowledged the underperformance and is undertaking a “regional reset,” including adjustments to the go-to-market approach and cost structure. Investors should watch how quickly these changes translate into stabilization or renewed growth in this important geography.
Injection Molding and 3D Printing Face Prototyping Headwinds
While CNC and sheet metal thrived, some legacy areas lagged. Injection molding revenue fell 1.9% for the year, impacted by weaker medical device demand and a broader slowdown in prototyping activity. 3D printing revenue declined 4.7% year over year, hurt by softness in plastic prototypes and older technologies. One bright spot: U.S. metal 3D printing (DMLS) posted double-digit growth, suggesting higher-end applications remain healthy even as more commoditized prototyping comes under pressure.
Network Margins Squeezed by Tariffs and Complexity
Margins in the partner network came under pressure. Network non-GAAP gross margin fell about 190 basis points year over year to roughly 31%, with fourth quarter network margin at 30.3%. Management attributed the decline mainly to inefficiencies related to tariffs and the complexities of fulfilling work through the network. Improving network profitability is likely to be an important focus as the company refines its operating model in 2026.
Operating Expenses Rise Amid Transformation Costs
Operating costs ticked higher as Proto Labs invested in its team and transformation efforts. Fourth quarter non-GAAP operating expenses increased $5.2 million year over year, driven by higher incentive compensation, sales commissions, and medical expenses. For the full year, non-GAAP operating expenses were $193.3 million, or 36.3% of revenue, slightly above 36.0% in the prior year. Management also flagged additional transformation and restructuring costs as part of its 2026 initiatives, signaling short-term margin pressure in service of long-term efficiency.
Soft Start to 2026 and Fewer Unique Buyers
Management described early 2026 demand as “normalizing” following a strong fourth quarter, with a typical post-holiday slowdown in January. As a result, the company expects a softer sequential first quarter despite year-over-year growth. Investors also pressed on customer metrics: unique developers and contacts have fallen to the lowest level in some time. Management emphasized its focus on boosting revenue per contact but acknowledged that sustainable growth ultimately requires increasing both the number of active contacts and the spend per contact.
2026 Guidance and Transformation Blueprint
Looking ahead, Proto Labs guided for full-year 2026 GAAP revenue growth of 6–8% and projected first-quarter revenue between $130 million and $138 million, with the midpoint implying roughly 6% year-over-year growth, helped by a modest favorable currency impact. The company expects first-quarter non-GAAP EPS of $0.36–$0.44 and outlined full-year non-GAAP assumptions that incorporate stock-based compensation, amortization, and transformation and restructuring costs, alongside a 24–25% effective tax rate. Management framed 2026 as a strategic transition year built on four pillars—enhancing customer experience, accelerating innovation, expanding production capabilities, and improving operational efficiency—and reiterated a longer-term ambition to reach $1 billion in revenue with higher margins.
Proto Labs’ earnings call presented a company at an inflection point: delivering record results and strong cash flow while confronting pockets of weakness and committing to a comprehensive transformation. With CNC and sheet metal businesses surging, a rock-solid balance sheet, and targeted moves into higher-value production and regulated markets, the growth story remains intact. Execution on European restructuring, network margin improvement, and customer acquisition will be critical as 2026 unfolds, but the overall tone suggests a management team confident that today’s investments will lay the groundwork for stronger, more profitable growth in the years ahead.
